David Fiellin, MD

• Ajay Manhapra
• Amy Justice
• Andreas Coppi
• Andrew Taylor
• Anne C. Black
• Arjun Venkatesh
• Ayana Jordan
• Benjamin Howell
• Brent A Moore
• Carolyn M. Mazure
• Christopher Cutter
• Christopher T Rentsch
• Daniel G Tobin
• David Chartash
• Debbie Humphries
• Declan Barry
• Denise Esserman
• E. Jennifer Edelman
• Edouard Coupet
• Emma Biegacki
• Frederick Lewis Altice
• Gail D'Onofrio
• Geliang Gan
• Harlan Krumholz
• Henry Yaggi
• Hongyu Zhao
• James Dziura
• Jeanette Tetrault
• Jesse Reynolds
• Jody L. Sindelar
• John Concato
• Joseph Lim
• Joseph Lucien Goulet
• Julie R Gaither
• Kathleen Akgün
• Kathryn Hawk
• Kenneth Morford
• Kimberly Hieftje
• Kimberly Sue
• Kirsha Gordon, PhD, MS
• Lauretta Grau
• Leslie Curry
• Linda Degutis
• Linda Niccolai
• Lisa Fucito
• Lynn E Fiellin
• Marek Chawarski
• Melissa Weimer
• Michael Remetz
• Patrick G. O'Connor
• Radu Radulescu
• Rani Hoff
• Richard Schottenfeld
• Robert Heimer
• Robert Kerns
• Robert Rosenheck
• Ryan McNeil
• Srinivas Muvvala
• Stephen Baldassarri
• Stephen Holt
• Steve Martino
• Susan Busch
• Tassos C. Kyriakides
• Wade Schulz
• William Becker

Alcoholism; Buprenorphine; Health Policy; HIV; Internal Medicine; Opioid-Related Disorders; Public Health; Substance Withdrawal Syndrome; Tobacco Use Disorder; Substance Abuse Detection; Substance Abuse Treatment Centers; Clinical Trial; Multicenter Study; Meta-Analysis; Health Care Quality, Access, and Evaluation; Cocaine-Related Disorders; Alcohol-Related Disorders; Drug Overdose; Observational Study; Addiction Medicine; Marijuana Use; Implementation Science; Systematic Review

• Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17Heimer R, Black A, Lin H, Grau L, Fiellin D, Howell B, Hawk K, D'Onofrio G, Becker W. Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17. Drug And Alcohol Dependence 2023, 254: 111040. PMID: 38043226, PMCID: PMC10872282, DOI: 10.1016/j.drugalcdep.2023.111040.
• Computational phenotypes for patients with opioid-related disorders presenting to the emergency departmentTaylor R, Gilson A, Schulz W, Lopez K, Young P, Pandya S, Coppi A, Chartash D, Fiellin D, D’Onofrio G. Computational phenotypes for patients with opioid-related disorders presenting to the emergency department. PLOS ONE 2023, 18: e0291572. PMID: 37713393, PMCID: PMC10503758, DOI: 10.1371/journal.pone.0291572.
• Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral TherapyCartwright E, Pierret C, Minassian C, Esserman D, Tate J, Goetz M, Bhattacharya D, Fiellin D, Justice A, Re V, Rentsch C. Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy. JAMA Network Open 2023, 6: e2335715. PMID: 37751206, PMCID: PMC10523171, DOI: 10.1001/jamanetworkopen.2023.35715.
• Perspectives on contingency management for alcohol use and alcohol‐associated conditions among people in care with HIVCohen S, DePhilippis D, Deng Y, Dziura J, Ferguson T, Fucito L, Justice A, Maisto S, Marconi V, Molina P, Paris M, Rodriguez‐Barradas M, Simberkoff M, Petry N, Fiellin D, Edelman E. Perspectives on contingency management for alcohol use and alcohol‐associated conditions among people in care with HIV. Alcohol Clinical And Experimental Research 2023, 47: 1783-1797. PMID: 37524371, PMCID: PMC10828101, DOI: 10.1111/acer.15159.
• Long-Term Treatment of Opioid Use Disorder with MedicationsWolfgang A, Weimer M, Na P, Fiellin D, Muvvala S. Long-Term Treatment of Opioid Use Disorder with Medications. 2023 DOI: 10.1093/oxfordhb/9780197618431.013.23.
• URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEWCowan E, Perrone J, Dziura J, Edelman E, Hawk K, Herring A, McCormack R, Murphy A, Phadke M, Fiellin D, D'Onofrio G. URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEW. Journal Of Emergency Medicine 2023, 65: e357-e365. PMID: 37716904, PMCID: PMC10591927, DOI: 10.1016/j.jemermed.2023.06.007.
• Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized TrialMuvvala S, Gan G, Morford K, Dziura J, Esserman D, Porter E, Chan P, Cornman D, Reynolds J, Yager J, Fiellin D, Edelman E. Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial. Journal Of Addiction Medicine 2023, 17: e388-e391. PMID: 37934538, PMCID: PMC10726383, DOI: 10.1097/adm.0000000000001192.
• Pilot Trial of a Smartphone-Based Intervention to Reduce Alcohol Consumption among Veterans with HIVTaylor E, Patel D, Marconi V, Whitmire A, Hansen N, Kershaw T, Fiellin D, Lauckner C. Pilot Trial of a Smartphone-Based Intervention to Reduce Alcohol Consumption among Veterans with HIV. Military Behavioral Health 2023, 11: 66-77. PMID: 38405355, PMCID: PMC10888529, DOI: 10.1080/21635781.2023.2221465.
• Efficacy of alcohol reduction interventions among people with HIV as evaluated by self-report and a phosphatidylethanol (PEth) outcome: protocol for a systematic review and individual participant data meta-analysisKane J, Allen I, Fatch R, Scheffler A, Emenyonu N, Puryear S, Chirayil P, So-Armah K, Kahler C, Magidson J, Conroy A, Edelman E, Woolf-King S, Parry C, Kiene S, Chamie G, Adong J, Go V, Cook R, Muyindike W, Morojele N, Blokhina E, Krupitsky E, Fiellin D, Hahn J. Efficacy of alcohol reduction interventions among people with HIV as evaluated by self-report and a phosphatidylethanol (PEth) outcome: protocol for a systematic review and individual participant data meta-analysis. BMJ Open 2023, 13: e070713. PMID: 37280036, PMCID: PMC10254608, DOI: 10.1136/bmjopen-2022-070713.
• Converging Evidence from Rodent and Human Studies on the Role of Spironolactone as a Potential Pharmacotherapy for Alcohol Use DisorderFarokhnia M, Rentsch C, Chuong V, McGinn M, Elvig S, Douglass E, Gonzalez L, Sanfilippo J, Marchette R, Tunstall B, Fiellin D, Koob G, Justice A, Leggio L, Vendruscolo L. Converging Evidence from Rodent and Human Studies on the Role of Spironolactone as a Potential Pharmacotherapy for Alcohol Use Disorder. Alcohol 2023, 109: 83-84. DOI: 10.1016/j.alcohol.2023.03.071.
• Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trialEdelman E, Dziura J, Deng Y, DePhilippis D, Fucito L, Ferguson T, Bedimo R, Brown S, Marconi V, Goetz M, Rodriguez-Barradas M, Simberkoff M, Molina P, Weintrob A, Maisto S, Paris M, Justice A, Bryant K, Fiellin D. Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trial. Contemporary Clinical Trials 2023, 131: 107242. PMID: 37230168, PMCID: PMC10460633, DOI: 10.1016/j.cct.2023.107242.
• National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use DisorderCowan E, Perrone J, Bernstein S, Coupet E, Fiellin D, Hawk K, Herring A, Huntley K, McCormack R, Venkatesh A, D'Onofrio G. National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use Disorder. Annals Of Emergency Medicine 2023, 82: 326-335. PMID: 37178101, PMCID: PMC10524880, DOI: 10.1016/j.annemergmed.2023.03.025.
• Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards SurveysChen K, Oldfield B, Joudrey P, Biegacki E, Fiellin D. Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys. Journal Of Addiction Medicine 2023, 17: 544-550. PMID: 37788607, DOI: 10.1097/adm.0000000000001174.
• Perspectives on and experiences of emergency department–initiated buprenorphine among clinical pharmacists: A multi-site qualitative studyJusten M, Edelman E, Chawarski M, Coupet E, Cowan E, Lyons M, Owens P, Martel S, Richardson L, Rothman R, Whiteside L, O'Connor P, Zahn E, D'Onofrio G, Fiellin D, Hawk K. Perspectives on and experiences of emergency department–initiated buprenorphine among clinical pharmacists: A multi-site qualitative study. Journal Of Substance Use And Addiction Treatment 2023, 155: 209058. PMID: 37149149, DOI: 10.1016/j.josat.2023.209058.
• Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled TrialMcCormack R, Rotrosen J, Gauthier P, D'Onofrio G, Fiellin D, Marsch L, Novo P, Liu D, Edelman E, Farkas S, Matthews A, Mulatya C, Salazar D, Wolff J, Knight R, Goodman W, Williams J, Hawk K. Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled Trial. Annals Of Emergency Medicine 2023, 82: 272-287. PMID: 37140493, PMCID: PMC10524047, DOI: 10.1016/j.annemergmed.2023.02.013.
• Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine ProgramsSue K, Chawarski M, Curry L, McNeil R, Coupet E, Schwartz R, Wilder C, Tsui J, Hawk K, D’Onofrio G, O’Connor P, Fiellin D, Edelman E. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs. JAMA Network Open 2023, 6: e2312718. PMID: 37163263, PMCID: PMC10173026, DOI: 10.1001/jamanetworkopen.2023.12718.
• Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US StatesJoudrey P, Chen K, Oldfield B, Biegacki E, Fiellin D. Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States. Journal Of Addiction Medicine 2023, 17: 615-617. PMID: 37788621, PMCID: PMC10591456, DOI: 10.1097/adm.0000000000001170.
• Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use DisorderD’Onofrio G, Edelman E, Hawk K, Chawarski M, Pantalon M, Owens P, Martel S, Rothman R, Saheed M, Schwartz R, Cowan E, Richardson L, Salsitz E, Lyons M, Freiermuth C, Wilder C, Whiteside L, Tsui J, Klein J, Coupet E, O’Connor P, Matthews A, Murphy S, Huntley K, Fiellin D. Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder. JAMA Network Open 2023, 6: e235439. PMID: 37017967, PMCID: PMC10077107, DOI: 10.1001/jamanetworkopen.2023.5439.
• Availability of Specific Programs and Medications for Addiction Treatment to Vulnerable Populations: Results from the Addiction Treatment Locator, Assessment, and Standards (ATLAS) SurveyOldfield B, Chen K, Joudrey P, Biegacki E, Fiellin D. Availability of Specific Programs and Medications for Addiction Treatment to Vulnerable Populations: Results from the Addiction Treatment Locator, Assessment, and Standards (ATLAS) Survey. Journal Of Addiction Medicine 2023, 17: 477-480. PMID: 37579115, DOI: 10.1097/adm.0000000000001158.
• Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of FentanylD’Onofrio G, Hawk K, Perrone J, Walsh S, Lofwall M, Fiellin D, Herring A. Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. JAMA Network Open 2023, 6: e236108. PMID: 36995717, PMCID: PMC10064247, DOI: 10.1001/jamanetworkopen.2023.6108.
• Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysisHowell B, Black A, Grau L, Lin H, Greene C, Lee H, Heimer R, Hawk K, D'Onofrio G, Fiellin D, Becker W. Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis. Drug And Alcohol Dependence 2023, 244: 109788. PMID: 36738634, PMCID: PMC9975083, DOI: 10.1016/j.drugalcdep.2023.109788.
• Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus TreatmentHaque L, Fiellin D, Tate J, Esserman D, Bhattacharya D, Butt A, Crystal S, Edelman E, Gordon A, Lim J, Tetrault J, Williams E, Bryant K, Cartwright E, Rentsch C, Justice A, Re V, McGinnis K. Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment. JAMA Network Open 2022, 5: e2246604. PMID: 36515952, PMCID: PMC9856353, DOI: 10.1001/jamanetworkopen.2022.46604.
• Outcomes of Patients with Opioid-Related Diagnoses in Acute Coronary Syndrome: a National Inpatient Sample-Based AnalysisKim Y, Pacor J, Do A, Brennan J, Fiellin D, Edelman E. Outcomes of Patients with Opioid-Related Diagnoses in Acute Coronary Syndrome: a National Inpatient Sample-Based Analysis. Journal Of General Internal Medicine 2022, 38: 563-570. PMID: 36376632, PMCID: PMC9971420, DOI: 10.1007/s11606-022-07399-3.
• Group-based medical mistrust and care expectations among black patients seeking addiction treatmentHall O, Bhadra-Heintz N, Teater J, Samiec J, Moreno J, Dixon-Shambley K, Rood K, Fiellin D, Jordan A. Group-based medical mistrust and care expectations among black patients seeking addiction treatment. Drug And Alcohol Dependence Reports 2022, 2: 100026. PMID: 36845897, PMCID: PMC9949334, DOI: 10.1016/j.dadr.2022.100026.
• Commentary Article: Strategic Planning for Addiction Programs within Academic Medical Centers: Examples from the Yale Program in Addiction MedicineBiegacki ET, Tetrault JM, Fiellin DA. Commentary Article: Strategic Planning for Addiction Programs within Academic Medical Centers: Examples from the Yale Program in Addiction Medicine. Substance Abuse 2022, 43: 1215-1220. PMID: 35657646, DOI: 10.1080/08897077.2022.2074606.
• 237 Urine Toxicology Profiles of Adult Emergency Department Patients With Untreated Opioid Use Disorder: National Data from 26 Emergency DepartmentsCowan E, Perrone J, Fiellin D, Edelman E, Hawk K, Herring A, McCormack R, D'Onofrio G. 237 Urine Toxicology Profiles of Adult Emergency Department Patients With Untreated Opioid Use Disorder: National Data from 26 Emergency Departments. Annals Of Emergency Medicine 2021, 78: s96. DOI: 10.1016/j.annemergmed.2021.09.249.
• 199 Extended-Release Injectable Buprenorphine for Emergency Department Patients with Opioid Use Disorder in Minimal WithdrawalD'Onofrio G, Herring A, Perrone J, Hawk K, Samuels E, Cowan E, McCormack R, DeVogel N, Dziura J, Fiellin D. 199 Extended-Release Injectable Buprenorphine for Emergency Department Patients with Opioid Use Disorder in Minimal Withdrawal. Annals Of Emergency Medicine 2021, 78: s80. DOI: 10.1016/j.annemergmed.2021.09.210.
• SOAPs and SUDs: Patients With Substance Use Disorders and What Clinicians Should Know About the Cures ActChan CA, Tetrault JM, Fiellin DA, Weimer MB. SOAPs and SUDs: Patients With Substance Use Disorders and What Clinicians Should Know About the Cures Act. Journal Of Addiction Medicine 2021, 16: 141-142. PMID: 34049315, DOI: 10.1097/adm.0000000000000879.
• Patients With Opioid Use Disorder Deserve Trained Providers.Weimer MB, Tetrault JM, Fiellin DA. Patients With Opioid Use Disorder Deserve Trained Providers. Annals Of Internal Medicine 2020, 172: 774-775. PMID: 32479150, DOI: 10.7326/l20-0084.
• Global opioid agonist treatment: a review of clinical practices by countryJin H, Marshall B, Degenhardt L, Strang J, Hickman M, Fiellin D, Ali R, Bruneau J, Larney S. Global opioid agonist treatment: a review of clinical practices by country. Addiction 2020, 115: 2243-2254. PMID: 32289189, PMCID: PMC7554123, DOI: 10.1111/add.15087.
• Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated BuprenorphineHawk KF, D’Onofrio G, Chawarski MC, O’Connor P, Cowan E, Lyons MS, Richardson L, Rothman RE, Whiteside LK, Owens PH, Martel SH, Coupet E, Pantalon M, Curry L, Fiellin DA, Edelman EJ. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine. JAMA Network Open 2020, 3: e204561. PMID: 32391893, PMCID: PMC7215257, DOI: 10.1001/jamanetworkopen.2020.4561.
• When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid CrisisBecker WC, Fiellin DA. When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis. Annals Of Internal Medicine 2020, 173: m20-1210. PMID: 32240291, PMCID: PMC7138333, DOI: 10.7326/m20-1210.
• Patients With Opioid Use Disorder Deserve Trained Providers.Weimer MB, Tetrault JM, Fiellin DA. Patients With Opioid Use Disorder Deserve Trained Providers. Annals Of Internal Medicine 2019, 171: 931-932. PMID: 31766053, DOI: 10.7326/m19-2303.
• Vaping—Seeking Clarity in a Time of UncertaintyBaldassarri SR, Fiellin DA, Friedman AS. Vaping—Seeking Clarity in a Time of Uncertainty. JAMA 2019, 322: 1951-1952. PMID: 31697311, PMCID: PMC8284981, DOI: 10.1001/jama.2019.16493.
• 260 Perceptions and Experiences of Emergency Department Patients With Opioid Use DisorderHawk K, McCormack R, Edelman E, Coupet E, Toledo N, Gauiter P, Rotrosen J, Chawarski M, 0069 and 0079 and Researchers C, Fiellin D, D'Onofrio G. 260 Perceptions and Experiences of Emergency Department Patients With Opioid Use Disorder. Annals Of Emergency Medicine 2019, 74: s102. DOI: 10.1016/j.annemergmed.2019.08.218.
• 159 Implementing Emergency Department-Initiated Buprenorphine in Low-Resource, High-Need SettingsMcCormack R, Hawk K, D'Onofrio G, Rotrosen J, Gauthier P, Edelman E, Fiellin D, Novo P, Marsch L, Knight R, Goodman W. 159 Implementing Emergency Department-Initiated Buprenorphine in Low-Resource, High-Need Settings. Annals Of Emergency Medicine 2019, 74: s62-s63. DOI: 10.1016/j.annemergmed.2019.08.165.
• Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trialEdelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, Fiellin LE, O'Connor PG, Bedimo R, Gibert CL, Marconi VC, Rimland D, Rodriguez-Barradas MC, Simberkoff MS, Tate JP, Justice AC, Bryant KJ, Fiellin DA. Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial. The Lancet HIV 2019, 6: e509-e517. PMID: 31109915, PMCID: PMC7161741, DOI: 10.1016/s2352-3018(19)30076-1.
• 3575 Assessing Research Activity and Capacity of Community Based Organizations: Field Testing of the Community Research Activity Assessment Tool (CREAT)Walker M, Ray N, Fiellin D, Humphries D. 3575 Assessing Research Activity and Capacity of Community Based Organizations: Field Testing of the Community Research Activity Assessment Tool (CREAT). Journal Of Clinical And Translational Science 2019, 3: 84-84. PMCID: PMC6799104, DOI: 10.1017/cts.2019.194.
• Association of Prescribed Opioids With Increased Risk of Community-Acquired Pneumonia Among Patients With and Without HIVEdelman EJ, Gordon KS, Crothers K, Akgün K, Bryant KJ, Becker WC, Gaither JR, Gibert CL, Gordon AJ, Marshall BDL, Rodriguez-Barradas MC, Samet JH, Justice AC, Tate JP, Fiellin DA. Association of Prescribed Opioids With Increased Risk of Community-Acquired Pneumonia Among Patients With and Without HIV. JAMA Internal Medicine 2019, 179: 297-304. PMID: 30615036, PMCID: PMC6439696, DOI: 10.1001/jamainternmed.2018.6101.
• SU137DIFFERENCES DETWEEN AUDIT-C AND AUD PHENOTYPES REVEALED BY GENOME-WIDE ANALYSISKember R, Zhou H, Justice A, Smith R, Tate J, Becker W, Concato J, Fiellin D, Xu K, Zhao H, Gelernter J, Kranzler H. SU137DIFFERENCES DETWEEN AUDIT-C AND AUD PHENOTYPES REVEALED BY GENOME-WIDE ANALYSIS. European Neuropsychopharmacology 2019, 29: s1339-s1340. DOI: 10.1016/j.euroneuro.2018.08.501.
• 2224. Receipt and Virologic Outcomes of HCV Direct-Acting Antivirals by Alcohol Use and HIV StatusCartwright E, Rentsch C, Esserman D, Tate J, Fiellin D, Lo Re V, Justice A, . 2224. Receipt and Virologic Outcomes of HCV Direct-Acting Antivirals by Alcohol Use and HIV Status. Open Forum Infectious Diseases 2018, 5: s657-s658. PMCID: PMC6253010, DOI: 10.1093/ofid/ofy210.1877.
• 5EMF Developing an Emergency Department-Based Intervention to Prevent Opioid Overdose: Listening to Patient VoicesHawk K, Grau L, Fiellin D, Pantalon M, Chawarski M, O'Connor P, D'Onofrio G. 5EMF Developing an Emergency Department-Based Intervention to Prevent Opioid Overdose: Listening to Patient Voices. Annals Of Emergency Medicine 2018, 72: s155. DOI: 10.1016/j.annemergmed.2018.08.402.
• Women and opioids: something different is happening hereMazure CM, Fiellin DA. Women and opioids: something different is happening here. The Lancet 2018, 392: 9-11. PMID: 30047402, DOI: 10.1016/s0140-6736(18)31203-0.
• Toward Better Stewardship: Gaining Control Over Controlled Substances.Fiellin LE, Fiellin DA. Toward Better Stewardship: Gaining Control Over Controlled Substances. Annals Of Internal Medicine 2018, 168: 883-884. PMID: 29799985, DOI: 10.7326/m18-1146.
• More Beds or More Chairs? Using a Science-Based Approach to Address the Opioid Epidemic.Tetrault JM, Fiellin DA. More Beds or More Chairs? Using a Science-Based Approach to Address the Opioid Epidemic. Annals Of Internal Medicine 2017, 168: 73-74. PMID: 29159399, DOI: 10.7326/m17-2854.
• Video Game Intervention for Sexual Risk Reduction in Minority Adolescents: Randomized Controlled TrialFiellin LE, Hieftje KD, Pendergrass TM, Kyriakides TC, Duncan LR, Dziura JD, Sawyer BG, Mayes L, Crusto CA, Forsyth BW, Fiellin DA. Video Game Intervention for Sexual Risk Reduction in Minority Adolescents: Randomized Controlled Trial. Journal Of Medical Internet Research 2017, 19: e314. PMID: 28923788, PMCID: PMC5625130, DOI: 10.2196/jmir.8148.
• Limited evidence, faulty reasoning, and potential for a global opioid crisisBecker WC, Fiellin DA. Limited evidence, faulty reasoning, and potential for a global opioid crisis. The BMJ 2017, 358: j3115. PMID: 28679499, DOI: 10.1136/bmj.j3115.
• Abuse-Deterrent Opioid Formulations — Putting the Potential Benefits into PerspectiveBecker WC, Fiellin DA. Abuse-Deterrent Opioid Formulations — Putting the Potential Benefits into Perspective. New England Journal Of Medicine 2017, 376: 2103-2105. PMID: 28564568, DOI: 10.1056/nejmp1701553.
• HIV pre-exposure prophylaxis for people who inject drugs: Willingness to prescribe among general internistsEdelman E, Moore B, Berkenblit G, Calabrese S, Cunningham C, Fiellin D, Patel V, Phillips K, Tetrault J, Shah M, Blackstock O. HIV pre-exposure prophylaxis for people who inject drugs: Willingness to prescribe among general internists. Drug And Alcohol Dependence 2017, 171: e58. DOI: 10.1016/j.drugalcdep.2016.08.170.
• The effect of substance use disorders on the association between guideline-concordant long-term opioid therapy and all-cause mortalityGaither J, Goulet J, Becker W, Crystal S, Edelman E, Gordon K, Kerns R, Rimland D, Skanderson M, Justice A, Fiellin D. The effect of substance use disorders on the association between guideline-concordant long-term opioid therapy and all-cause mortality. Drug And Alcohol Dependence 2017, 171: e68. DOI: 10.1016/j.drugalcdep.2016.08.196.
• Prescribing opioids safely in the emergency department study: Predictors of emergency department discharge with high morphine milligram equivalent prescriptionHawk K, Weiner S, Dziura J, Fiellin D, DaEun D, Nelson L, Hoppe J, Perrone J, D’Onofrio G. Prescribing opioids safely in the emergency department study: Predictors of emergency department discharge with high morphine milligram equivalent prescription. Drug And Alcohol Dependence 2017, 171: e86. DOI: 10.1016/j.drugalcdep.2016.08.242.
• “The devil I know is better than the devil I don’t know”: Enrollment in a pilot trial of opioid dose escalation vs. buprenorphine/naloxone for painManhapra A, Fiellin D, Becker W. “The devil I know is better than the devil I don’t know”: Enrollment in a pilot trial of opioid dose escalation vs. buprenorphine/naloxone for pain. Drug And Alcohol Dependence 2017, 171: e128. DOI: 10.1016/j.drugalcdep.2016.08.356.
• Can Primary Care Practices Help Address the Health Crisis Fueled by Prescription Opioids?Edelman EJ, Fiellin DA. Can Primary Care Practices Help Address the Health Crisis Fueled by Prescription Opioids? Annals Of Internal Medicine 2016, 166: 307-308. PMID: 27919106, DOI: 10.7326/m16-2666.
• Primary Care Physicians’ Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject DrugsEdelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham C, Patel V, Phillips K, Tetrault JM, Shah M, Fiellin DA, Blackstock O. Primary Care Physicians’ Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs. AIDS And Behavior 2016, 21: 1025-1033. PMID: 27896552, PMCID: PMC5344709, DOI: 10.1007/s10461-016-1612-6.
• A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care PhysiciansBlackstock OJ, Moore BA, Berkenblit GV, Calabrese SK, Cunningham CO, Fiellin DA, Patel VV, Phillips KA, Tetrault JM, Shah M, Edelman EJ. A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians. Journal Of General Internal Medicine 2016, 32: 62-70. PMID: 27778215, PMCID: PMC5215171, DOI: 10.1007/s11606-016-3903-z.
• The impact of prescribed opioids on CD4 cell count recovery among HIV‐infected patients newly initiating antiretroviral therapyEdelman E, Gordon K, Tate J, Becker W, Bryant K, Crothers K, Gaither, Gibert C, Gordon A, Marshall B, Rodriguez‐Barradas M, Samet J, Skanderson M, Justice A, Fiellin D. The impact of prescribed opioids on CD4 cell count recovery among HIV‐infected patients newly initiating antiretroviral therapy. HIV Medicine 2016, 17: 728-739. PMID: 27186715, PMCID: PMC5053822, DOI: 10.1111/hiv.12377.
• Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-InfectionTetrault JM, Tate JP, Edelman EJ, Gordon AJ, Re V, Lim JK, Rimland D, Goulet J, Crystal S, Gaither JR, Gibert CL, Rodriguez-Barradas MC, Fiellin LE, Bryant K, Justice AC, Fiellin DA. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. Journal Of Substance Use And Addiction Treatment 2016, 68: 62-67. PMID: 27431048, PMCID: PMC4976086, DOI: 10.1016/j.jsat.2016.06.002.
• In the Clinic. Alcohol Use.Edelman EJ, Fiellin DA. In the Clinic. Alcohol Use. Annals Of Internal Medicine 2016, 164: itc1-16. PMID: 26747315, DOI: 10.7326/aitc201601050.
• Do prescribed opioids impact CD4 count restoration among HIV+ patients initiating antiretroviral therapy?Edelman E, Tate J, Gordon K, Becker W, Bryant K, Crothers K, Gaither J, Gibert C, Gordon A, Marshall B, Rodriguez-Barradas M, Samet J, Skanderson M, Justice A, Fiellin D. Do prescribed opioids impact CD4 count restoration among HIV+ patients initiating antiretroviral therapy? Drug And Alcohol Dependence 2015, 156: e63. DOI: 10.1016/j.drugalcdep.2015.07.1089.
• Mortality and guideline-concordant long-term opioid therapy for painGaither J, Goulet J, Becker W, Crystal S, Edelman E, Gordon K, Kerns R, Rimland D, Skanderson M, Justice A, Fiellin D. Mortality and guideline-concordant long-term opioid therapy for pain. Drug And Alcohol Dependence 2015, 156: e77. DOI: 10.1016/j.drugalcdep.2015.07.1127.
• Incident non-medical use of prescription opioids is associated with heroin initiation among U.S. veterans: A prospective cohort studyBanerjee G, Edelman E, Barry D, Becker W, Cerda M, Crystal S, Gaither J, Gordon A, Gordon K, Kerns R, Martins S, Fiellin D, Marshall B. Incident non-medical use of prescription opioids is associated with heroin initiation among U.S. veterans: A prospective cohort study. Drug And Alcohol Dependence 2015, 156: e14-e15. DOI: 10.1016/j.drugalcdep.2015.07.958.
• A randomized clinical trial of emergency department initiated treatment for opioid dependence: Two and six month outcomesD’Onofrio G, O’Connor P, Pantalon M, Chawarski M, Busch S, Owens P, Bernstein S, Fiellin D. A randomized clinical trial of emergency department initiated treatment for opioid dependence: Two and six month outcomes. Drug And Alcohol Dependence 2015, 156: e53. DOI: 10.1016/j.drugalcdep.2015.07.1062.
• Health service use in a randomized clinical trial comparing three methods of emergency department interventions for opioid dependenceBusch S, Hawk K, Fiellin D, O’Connor P, Chawarski M, Owens P, Pantalon M, Bernstein S, D’Onofrio G. Health service use in a randomized clinical trial comparing three methods of emergency department interventions for opioid dependence. Drug And Alcohol Dependence 2015, 156: e32. DOI: 10.1016/j.drugalcdep.2015.07.1005.
• Testing the VACS index as a measure of health outcomes associated with abstinence among patients receiving opioid agonist treatmentFiellin D, McGinnis K, Tate J, Justice A. Testing the VACS index as a measure of health outcomes associated with abstinence among patients receiving opioid agonist treatment. Drug And Alcohol Dependence 2015, 156: e68. DOI: 10.1016/j.drugalcdep.2015.07.1103.
• PHS176 Patient Valuation of different approaches to mental health and Substance use disorder treatmentEpstein A, Barry C, Fiellin D, Busch S. PHS176 Patient Valuation of different approaches to mental health and Substance use disorder treatment. Value In Health 2015, 18: a277. DOI: 10.1016/j.jval.2015.03.1616.
• Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical TrialD’Onofrio G, O’Connor P, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial. JAMA 2015, 313: 1636-1644. PMID: 25919527, PMCID: PMC4527523, DOI: 10.1001/jama.2015.3474.
• Population, missing data and health care system viral loadEdelman E, Tate J, Fiellin D, Brown S, Bryant K, Gandhi N, Gibert C, Goetz M, Gordon K, Rodriguez-Barradas M, Braithwaite R, Rimland D, Justice A. Population, missing data and health care system viral load. HIV Medicine 2015, 16: 346-354. PMID: 25688937, PMCID: PMC4478104, DOI: 10.1111/hiv.12219.
• Receipt of opioid therapy guideline- concordant care among HIV+ and HIV− veteransGaither J, Edelman E, Becker W, Crystal S, Gordon K, Goulet J, Kerns R, Skanderson M, Weisberg D, Bryant K, Justice A, Fiellin D. Receipt of opioid therapy guideline- concordant care among HIV+ and HIV− veterans. Drug And Alcohol Dependence 2015, 146: e119. DOI: 10.1016/j.drugalcdep.2014.09.242.
• Willingness to enter drug treatment: The role of treatment models, copays and financial incentivesBarry C, Busch S, Epstein A, Fiellin D. Willingness to enter drug treatment: The role of treatment models, copays and financial incentives. Drug And Alcohol Dependence 2015, 146: e218. DOI: 10.1016/j.drugalcdep.2014.09.061.
• Using the VACS index to track health outcomes associated with abstinence among HIV-infected patients receiving opioid agonist treatmentMcGinnis K, Edelman E, Tate J, Justice A, Fiellin D. Using the VACS index to track health outcomes associated with abstinence among HIV-infected patients receiving opioid agonist treatment. Drug And Alcohol Dependence 2015, 146: e201. DOI: 10.1016/j.drugalcdep.2014.09.462.
• PlayForward: A videogame that increases drug, alcohol and sexual risk knowledge in teensFiellin L, Hieftje K, Fakhouri T, Duncan L, Sawyer B, Fiellin D. PlayForward: A videogame that increases drug, alcohol and sexual risk knowledge in teens. Drug And Alcohol Dependence 2015, 146: e277-e278. DOI: 10.1016/j.drugalcdep.2014.09.221.
• Cognitive behavioral therapy improves treatment outcome for prescription opioid users in primary care based buprenorphine/naloxone treatmentCutter C, Moore B, Barry D, Fiellin L, Schottenfeld R, Fiellin D, O’Connor P. Cognitive behavioral therapy improves treatment outcome for prescription opioid users in primary care based buprenorphine/naloxone treatment. Drug And Alcohol Dependence 2015, 146: e255. DOI: 10.1016/j.drugalcdep.2014.09.160.
• Primary care buprenorphine detoxification vs. maintenance for prescription opioid dependenceFiellin D, Cutter C, Moore B, Barry D, O’Connor P, Schottenfeld R. Primary care buprenorphine detoxification vs. maintenance for prescription opioid dependence. Drug And Alcohol Dependence 2015, 146: e277. DOI: 10.1016/j.drugalcdep.2014.09.220.
• Dose and other factors associated with decreased pain intensity among patients initiating buprenorphine/naloxoneBecker W, Ganoczy D, Fiellin D, Bohnert A. Dose and other factors associated with decreased pain intensity among patients initiating buprenorphine/naloxone. Drug And Alcohol Dependence 2015, 146: e221. DOI: 10.1016/j.drugalcdep.2014.09.068.
• Primary Care–Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence: A Randomized Clinical TrialFiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O’Connor P. Primary Care–Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence: A Randomized Clinical Trial. JAMA Internal Medicine 2014, 174: 1947-1954. PMID: 25330017, PMCID: PMC6167926, DOI: 10.1001/jamainternmed.2014.5302.
• Assessing Research Activity and Capacity of Community-Based Organizations: Development and Pilot Testing of an InstrumentHumphries D, Carroll-Scott A, Mitchell L, Tian T, Choudhury S, Fiellin D. Assessing Research Activity and Capacity of Community-Based Organizations: Development and Pilot Testing of an Instrument. Progress In Community Health Partnerships Research Education And Action 2014, 8: 413-414. DOI: 10.1353/cpr.2014.0055.
• The Impact of Recent Cocaine Use on Plasma Levels of Methadone and Buprenorphine in Patients with and Without HIV-infectionTetrault JM, McCance-Katz EF, Moody DE, Fiellin DA, Lruie BS, DInh AT, Fiellin LE. The Impact of Recent Cocaine Use on Plasma Levels of Methadone and Buprenorphine in Patients with and Without HIV-infection. Journal Of Substance Use And Addiction Treatment 2014, 51: 70-74. PMID: 25480096, DOI: 10.1016/j.jsat.2014.10.010.
• OSA and HIV infectionKunisaki K, Akgün K, Fiellin D, Gibert C, Kim J, Rimland D, Rodriguez‐Barradas M, Yaggi H, Crothers K. OSA and HIV infection. HIV Medicine 2014, 16: 105-113. PMID: 25230851, PMCID: PMC4300288, DOI: 10.1111/hiv.12182.
• Substance use in older HIV-infected patientsEdelman EJ, Tetrault JM, Fiellin DA. Substance use in older HIV-infected patients. Current Opinion In HIV And AIDS 2014, 9: 317-324. PMID: 24824888, PMCID: PMC4175926, DOI: 10.1097/coh.0000000000000069.
• Federal parity does not lead to large increases in spending on substance use disorder treatment: Results from year 1Busch S, Epstein A, Harhay M, Fiellin D, Un H, Leader D, Barry C. Federal parity does not lead to large increases in spending on substance use disorder treatment: Results from year 1. Drug And Alcohol Dependence 2014, 140: e23. DOI: 10.1016/j.drugalcdep.2014.02.085.
• Quality of HIV care and mortality in HIV-infected patients who use drugs and alcoholKorthuis P, Kraemer K, McGinnis K, Skanderson M, Gordon A, Justice A, Fiellin D. Quality of HIV care and mortality in HIV-infected patients who use drugs and alcohol. Drug And Alcohol Dependence 2014, 140: e110. DOI: 10.1016/j.drugalcdep.2014.02.317.
• A videogame for substance use prevention and HIV risk reduction in young adolescentsFiellin L, Hieftje K, Duncan L, Sawyer B, Fiellin D. A videogame for substance use prevention and HIV risk reduction in young adolescents. Drug And Alcohol Dependence 2014, 140: e58-e59. DOI: 10.1016/j.drugalcdep.2014.02.179.
• HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatmentEdelman E, Moore B, Caffrey S, Sikkema K, Jones E, Schottenfeld R, Fiellin D, Fiellin L. HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment. Drug And Alcohol Dependence 2014, 140: e54. DOI: 10.1016/j.drugalcdep.2014.02.167.
• Systematic evidence review on methadone harms and comparative harmsChou R, Weimer M, Fiellin D. Systematic evidence review on methadone harms and comparative harms. Drug And Alcohol Dependence 2014, 140: e34. DOI: 10.1016/j.drugalcdep.2014.02.113.
• Racial/ethnic differences in report of drug testing practices at the workplace level in the U.S.Becker WC, Meghani S, Tetrault JM, Fiellin DA. Racial/ethnic differences in report of drug testing practices at the workplace level in the U.S. American Journal On Addictions 2013, 23: 357-362. PMID: 24112118, DOI: 10.1111/j.1521-0391.2013.12109.x.
• P315: Sexual risk behaviors among minority men who have sex with men with and without HIVGordon K, Edelman J, Justice A, Crystal S, Rimland D, Duggal M, Fiellin D, Bryant K. P315: Sexual risk behaviors among minority men who have sex with men with and without HIV. Antimicrobial Resistance & Infection Control 2013, 2: p315. PMCID: PMC3688234, DOI: 10.1186/2047-2994-2-s1-p315.
• PHS141 Effects Of Federal Parity On Substance Use Disorder TreatmentBusch S, Epstein A, Fiellin D, Un H, Leader D, Harhay M, Barry C. PHS141 Effects Of Federal Parity On Substance Use Disorder Treatment. Value In Health 2013, 16: a211. DOI: 10.1016/j.jval.2013.03.1066.
• Treating Pain in Patients Receiving Methadone Maintenance for Opioid DependenceAlford D, Barry D, Fiellin D. Treating Pain in Patients Receiving Methadone Maintenance for Opioid Dependence. 2013, 31-37. DOI: 10.1007/978-1-4614-6974-2_3.
• Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist TreatmentTetrault JM, Kozal MJ, Chiarella J, Sullivan LE, Dinh AT, Fiellin DA. Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment. Journal Of Addiction Medicine 2013, 7: 102-107. PMID: 23388678, PMCID: PMC3618545, DOI: 10.1097/adm.0b013e31827f9bdf.
• Project ART-ED: alcohol reduction and HIV testing in the emergency departmentEdelman E, Dinh A, Radu-Radulescu L, Lurie B, Tetrault J, D'Onofrio G, Fiellin D, Fiellin L. Project ART-ED: alcohol reduction and HIV testing in the emergency department. Addiction Science & Clinical Practice 2012, 7: a35. PMCID: PMC3480109, DOI: 10.1186/1940-0640-7-s1-a35.
• Physician Detection of Unhealthy Substance Use on Inpatient Teaching and Hospitalist Medical ServicesHolt SR, Ramos J, Harma M, Cabrera F, Louis-Ashby C, Dinh A, Fiellin DA, Tetrault JM. Physician Detection of Unhealthy Substance Use on Inpatient Teaching and Hospitalist Medical Services. The American Journal Of Drug And Alcohol Abuse 2012, 39: 121-129. PMID: 22992028, DOI: 10.3109/00952990.2012.715703.
• Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patientsTetrault JM, Moore BA, Barry DT, O'Connor PG, Schottenfeld R, Fiellin DA, Fiellin LE. Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. Journal Of Substance Use And Addiction Treatment 2012, 43: 433-439. PMID: 22938914, DOI: 10.1016/j.jsat.2012.07.011.
• Previous Use of Alcohol, Cigarettes, and Marijuana and Subsequent Abuse of Prescription Opioids in Young AdultsFiellin LE, Tetrault JM, Becker WC, Fiellin DA, Hoff RA. Previous Use of Alcohol, Cigarettes, and Marijuana and Subsequent Abuse of Prescription Opioids in Young Adults. Journal Of Adolescent Health 2012, 52: 158-163. PMID: 23332479, PMCID: PMC3552239, DOI: 10.1016/j.jadohealth.2012.06.010.
• Federal plan for prescriber education on opioids misses opportunities.Becker WC, Fiellin DA. Federal plan for prescriber education on opioids misses opportunities. Annals Of Internal Medicine 2012, 157: 205-6. PMID: 22868838, DOI: 10.7326/0003-4819-157-3-201208070-00448.
• Combining Rapid HIV Testing and a Brief Alcohol Intervention in Young Unhealthy Drinkers in the Emergency Department: A Pilot StudyEdelman EJ, Dinh A, Radulescu R, Lurie B, D'Onofrio G, Tetrault JM, Fiellin DA, Fiellin LE. Combining Rapid HIV Testing and a Brief Alcohol Intervention in Young Unhealthy Drinkers in the Emergency Department: A Pilot Study. The American Journal Of Drug And Alcohol Abuse 2012, 38: 539-543. PMID: 22794939, PMCID: PMC3522092, DOI: 10.3109/00952990.2012.701359.
• Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Alcohol and Other Drug Use among Adolescents: Evaluation of a Pediatric Residency CurriculumRyan SA, Martel S, Pantalon M, Martino S, Tetrault J, Thung SF, Bernstein SL, Auinger P, Green ML, Fiellin DA, O'Connor P, D'Onofrio G. Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Alcohol and Other Drug Use among Adolescents: Evaluation of a Pediatric Residency Curriculum. Substance Abuse 2012, 33: 251-260. PMID: 22738002, DOI: 10.1080/08897077.2011.640182.
• Receptiveness To Smoking Cessation Among HIV-Infected And Uninfected PatientsShahrir S, McGinnis K, Tindle H, Fiellin D, Goulet J, Akgun K, Gibert C, Rodriguez-Barradas M, Engelberg R, Crothers K. Receptiveness To Smoking Cessation Among HIV-Infected And Uninfected Patients. 2012, a2589-a2589. DOI: 10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2589.
• Developing and Implementing a Multispecialty Graduate Medical Education Curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT)Tetrault JM, Green ML, Martino S, Thung SF, Degutis LC, Ryan SA, Martel S, Pantalon MV, Bernstein SL, O'Connor P, Fiellin DA, D'Onofrio G. Developing and Implementing a Multispecialty Graduate Medical Education Curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT). Substance Abuse 2012, 33: 168-181. PMID: 22489589, DOI: 10.1080/08897077.2011.640220.
• Opioid prescribing among HIV-infected and uninfected patientsGordon K, Edelman E, Skanderson M, Gaither J, Goulet J, Becker W, Gordon A, Braden J, Kerns R, Justice A, Fiellin D. Opioid prescribing among HIV-infected and uninfected patients. Journal Of Pain 2012, 13: s82. DOI: 10.1016/j.jpain.2012.01.339.
• Prevalence of Unhealthy Substance Use on Teaching and Hospitalist Medical Services: Implications for EducationHolt SR, Ramos J, Harma MA, Cabrera F, Louis‐Ashby C, Dinh A, Tetrault JM, Fiellin DA. Prevalence of Unhealthy Substance Use on Teaching and Hospitalist Medical Services: Implications for Education. American Journal On Addictions 2012, 21: 111-119. PMID: 22332853, DOI: 10.1111/j.1521-0391.2011.00207.x.
• Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent IndividualsTetrault JM, Fiellin DA. Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals. Drugs 2012, 72: 217-228. PMID: 22235870, PMCID: PMC3701303, DOI: 10.2165/11597520-000000000-00000.
• Reply to Letter “Additional Explanation for Lack of Pharmacodynamic Interaction Between Atazanavir and Buprenorphine Reported by Vergara-Rodriquez et al”Vergara-Rodriguez P, Tozzi M, Botsko M, Nandi V, Altice F, Egan J, O'Connor P, Sullivan L, Fiellin D. Reply to Letter “Additional Explanation for Lack of Pharmacodynamic Interaction Between Atazanavir and Buprenorphine Reported by Vergara-Rodriquez et al”. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2011, 58: e112-e113. DOI: 10.1097/qai.0b013e318232e955.
• Hepatic Safety and Antiretroviral Effectiveness in HIV‐Infected Patients Receiving NaltrexoneTetrault JM, Tate JP, McGinnis KA, Goulet JL, Sullivan LE, Bryant K, Justice AC, Fiellin DA, Team F. Hepatic Safety and Antiretroviral Effectiveness in HIV‐Infected Patients Receiving Naltrexone. Alcohol Clinical And Experimental Research 2011, 36: 318-324. PMID: 21797892, PMCID: PMC3221963, DOI: 10.1111/j.1530-0277.2011.01601.x.
• Nonmedical Use of Opioid Analgesics Obtained Directly From Physicians: Prevalence and CorrelatesBecker WC, Tobin DG, Fiellin DA. Nonmedical Use of Opioid Analgesics Obtained Directly From Physicians: Prevalence and Correlates. JAMA Internal Medicine 2011, 171: 1034-1036. PMID: 21670373, DOI: 10.1001/archinternmed.2011.217.
• A Meta‐analysis of the Efficacy of Nonphysician Brief Interventions for Unhealthy Alcohol Use: Implications for the Patient‐Centered Medical HomeSullivan LE, Tetrault JM, Braithwaite RS, Turner BJ, Fiellin DA. A Meta‐analysis of the Efficacy of Nonphysician Brief Interventions for Unhealthy Alcohol Use: Implications for the Patient‐Centered Medical Home. American Journal On Addictions 2011, 20: 343-356. PMID: 21679266, DOI: 10.1111/j.1521-0391.2011.00143.x.
• Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/NaloxoneFiellin DA, Weiss L, Botsko M, Egan JE, Altice FL, Bazerman LB, Chaudhry A, Cunningham CO, Gourevitch MN, Lum PJ, Sullivan LE, Schottenfeld RS, O'Connor PG. Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2011, 56: s33-s38. PMID: 21317592, PMCID: PMC3863630, DOI: 10.1097/qai.0b013e3182097537.
• Adding buprenorphine implants to counselling reduces opioid use over 6 months in opioid-dependent adultsTetrault JM, Fiellin DA. Adding buprenorphine implants to counselling reduces opioid use over 6 months in opioid-dependent adults. BMJ Mental Health 2011, 14: 30. PMID: 21266627, DOI: 10.1136/ebmh.14.1.30.
• Substance Use in Patients with Sexually Transmitted Infections: Results from a National U.S. SurveyTetrault JM, Fiellin DA, Niccolai LM, Sullivan LE. Substance Use in Patients with Sexually Transmitted Infections: Results from a National U.S. Survey. American Journal On Addictions 2010, 19: 504-509. PMID: 20958845, DOI: 10.1111/j.1521-0391.2010.00087.x.
• Health risk behaviors and injured patients: an exploratory studyDegutis C, Busch S, Pantalon M, Fiellin D, O'Connor P, D'Onofrio G. Health risk behaviors and injured patients: an exploratory study. Injury Prevention 2010, 16: a133. DOI: 10.1136/ip.2010.029215.477.
• Erratum to: Erectile Dysfunction Drug Receipt, Risky Sexual Behavior and Sexually Transmitted Diseases in HIVCook R, McGinnis K, Samet J, Fiellin D, Rodriguez-Barradas M, Kraemer K, Gibert C, Scott Braithwaite R, Goulet J, Mattocks K, Crystal S, Gordon A, Oursler K, Justice A. Erratum to: Erectile Dysfunction Drug Receipt, Risky Sexual Behavior and Sexually Transmitted Diseases in HIV. Journal Of General Internal Medicine 2010, 25: 1383-1383. PMCID: PMC2988141, DOI: 10.1007/s11606-010-1492-9.
• Opioids, Chronic Pain, and Addiction in Primary CareBarry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O'Connor PG, Schottenfeld RS, Fiellin DA. Opioids, Chronic Pain, and Addiction in Primary Care. Journal Of Pain 2010, 11: 1442-1450. PMID: 20627817, PMCID: PMC2955997, DOI: 10.1016/j.jpain.2010.04.002.
• Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative StudyBarry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O’Connor P, Schottenfeld RS, Fiellin DA. Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study. Journal Of General Internal Medicine 2008, 24: 218-225. PMID: 19089500, PMCID: PMC2628993, DOI: 10.1007/s11606-008-0881-9.
• Narrative review: buprenorphine for opioid-dependent patients in office practice.Sullivan LE, Fiellin DA. Narrative review: buprenorphine for opioid-dependent patients in office practice. Annals Of Internal Medicine 2008, 148: 662-70. PMID: 18458279, PMCID: PMC3694223, DOI: 10.7326/0003-4819-148-9-200805060-00006.
• W1050 Impact of Alcohol Abuse and Dependence On Liver Fibrosis in a Prospective Cohort of 6090 HIV+/Hiv- U.S. VeteransLim J, Fultz S, Goulet J, Conigliaro J, Bryant K, Gordon A, Gibert C, Fiellin D, Justice A. W1050 Impact of Alcohol Abuse and Dependence On Liver Fibrosis in a Prospective Cohort of 6090 HIV+/Hiv- U.S. Veterans. Gastroenterology 2008, 134: a-623. DOI: 10.1016/s0016-5085(08)62908-x.
• Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlatesBecker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug And Alcohol Dependence 2007, 94: 38-47. PMID: 18063321, DOI: 10.1016/j.drugalcdep.2007.09.018.
• Gender and non‐medical use of prescription opioids: results from a national US survey*Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non‐medical use of prescription opioids: results from a national US survey*. Addiction 2007, 103: 258-268. PMID: 18042194, DOI: 10.1111/j.1360-0443.2007.02056.x.
• Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic ReviewTetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic Review. JAMA Internal Medicine 2007, 167: 221-228. PMID: 17296876, PMCID: PMC2720277, DOI: 10.1001/archinte.167.3.221.
• Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Annals Of Internal Medicine 2007, 146: 116-27. PMID: 17227935, DOI: 10.7326/0003-4819-146-2-200701160-00006.
• A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical CareSullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA. A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care. Clinical Infectious Diseases 2006, 43: s184-s190. PMID: 17109305, DOI: 10.1086/508182.
• Evaluation of a Combined Online and in Person Training in the Use of BuprenorphineGunderson EW, Levin F, Kleber H, Fiellin D, Sullivan L. Evaluation of a Combined Online and in Person Training in the Use of Buprenorphine. Substance Abuse 2006, 27: 39-45. PMID: 17135179, PMCID: PMC3864017, DOI: 10.1300/j465v27n03_06.
• Training HIV Physicians to Prescribe Buprenorphine for Opioid DependenceSullivan LE, Tetrault J, Bangalore D, Fiellin DA. Training HIV Physicians to Prescribe Buprenorphine for Opioid Dependence. Substance Abuse 2006, 27: 13-18. PMID: 17135176, DOI: 10.1300/j465v27n03_03.
• Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid DependenceFiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O'Connor PG, Schottenfeld RS. Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence. New England Journal Of Medicine 2006, 355: 365-374. PMID: 16870915, DOI: 10.1056/nejmoa055255.
• The Association Between Marijuana Smoking and Lung Cancer: A Systematic ReviewMehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The Association Between Marijuana Smoking and Lung Cancer: A Systematic Review. JAMA Internal Medicine 2006, 166: 1359-1367. PMID: 16832000, DOI: 10.1001/archinte.166.13.1359.
• Faculty Development in Small-Group Teaching Skills Associated with a Training Course on Office-Based Treatment of Opioid DependenceWong JG, Holmboe ES, Becker W, Fiellin D, Jara G, Martin J. Faculty Development in Small-Group Teaching Skills Associated with a Training Course on Office-Based Treatment of Opioid Dependence. Substance Abuse 2005, 25: 35-40. PMID: 16172091, DOI: 10.1300/j465v25n04_05.
• Development and Implementation of an Emergency Practitioner–Performed Brief Intervention for Hazardous and Harmful Drinkers in the Emergency DepartmentD'Onofrio G, Pantalon M, Degutis L, Fiellin D, O'Connor P. Development and Implementation of an Emergency Practitioner–Performed Brief Intervention for Hazardous and Harmful Drinkers in the Emergency Department. Academic Emergency Medicine 2005, 12: 249-256. DOI: 10.1111/j.1553-2712.2005.tb00879.x.
• 100 Selective Methods Used in Alcohol Research Screening in Primary Care—Methods and ApproachesGordon A, Conigliaro J, Fiellin D. 100 Selective Methods Used in Alcohol Research Screening in Primary Care—Methods and Approaches. 2005, 1327-1345. DOI: 10.1016/b978-012564370-2/50102-1.
• Teaching brief intervention for alcohol problems to emergency practitioners: Development, implementation, and testing of a modelD'Onofrio G, Pantalon M, Degutis L, Fiellin D. Teaching brief intervention for alcohol problems to emergency practitioners: Development, implementation, and testing of a model. Annals Of Emergency Medicine 2004, 44: s78. DOI: 10.1016/j.annemergmed.2004.07.256.
• Counseling Requirements for Buprenorphine Maintenance in Primary CarePantalon M, Fiellin D, O’Connor P, Chawarski M, Pakes J, Schottenfeld R. Counseling Requirements for Buprenorphine Maintenance in Primary Care. Addictive Disorders & Their Treatment 2004, 3: 71-76. DOI: 10.1097/00132576-200406000-00003.
• Coordination of Medical Care and Opioid Dependence Treatment in Primary Care: A Case ReportFiellin D, Rosenheck R, Kosten T. Coordination of Medical Care and Opioid Dependence Treatment in Primary Care: A Case Report. Substance Abuse 2003, 24: 43-46. DOI: 10.1023/a:1022239400690.
• Editorial: Providing Opioid Agonist Maintenance Therapy in a Generalist's Office: The Physician's PerspectiveWong J, Kraus M, Feinberg M, Fiellin D. Editorial: Providing Opioid Agonist Maintenance Therapy in a Generalist's Office: The Physician's Perspective. Substance Abuse 2003, 24: 1-3. DOI: 10.1023/a:1022209731641.
• Providing Opioid Agonist Maintenance Therapy in a Generalist's Office: The Physician's PerspectiveWong J, Kraus M, Feinberg M, Fiellin D. Providing Opioid Agonist Maintenance Therapy in a Generalist's Office: The Physician's Perspective. Substance Abuse 2003, 24: 1-3. DOI: 10.1080/08897070309511528.
• New federal initiatives to enhance the medical treatment of opioid dependence.Fiellin DA, O'Connor PG. New federal initiatives to enhance the medical treatment of opioid dependence. Annals Of Internal Medicine 2002, 137: 688-92. PMID: 12379070, DOI: 10.7326/0003-4819-137-8-200210150-00014.
• Office-Based Treatment of Opioid-Dependent PatientsFiellin DA, O'Connor PG. Office-Based Treatment of Opioid-Dependent Patients. New England Journal Of Medicine 2002, 347: 817-823. PMID: 12226153, DOI: 10.1056/nejmcp013579.
• Risk for Delirium Tremens in Patients with Alcohol Withdrawal SyndromeFiellin D, O'Connor P, Holmboe E, Horwitz R. Risk for Delirium Tremens in Patients with Alcohol Withdrawal Syndrome. Substance Abuse 2002, 23: 83-94. DOI: 10.1023/a:1015350005418.
• Patients with Alcohol ProblemsFiellin D, Reid M, O'Connor P. Patients with Alcohol Problems. Annals Of Internal Medicine 2001, 135: 841. DOI: 10.7326/0003-4819-135-9-200111060-00020.
• Methadone Maintenance in Primary Care: A Randomized Controlled TrialFiellin DA, O'Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS. Methadone Maintenance in Primary Care: A Randomized Controlled Trial. JAMA 2001, 286: 1724-1731. PMID: 11594897, DOI: 10.1001/jama.286.14.1724.
• INNOVATIONS IN TREATMENT FOR DRUG ABUSE: Solutions to a Public Health ProblemSindelar J, Fiellin D. INNOVATIONS IN TREATMENT FOR DRUG ABUSE: Solutions to a Public Health Problem. Annual Review Of Public Health 2001, 22: 249-272. PMID: 11274521, DOI: 10.1146/annurev.publhealth.22.1.249.
• Treatment of Heroin DependenceO'Connor P, Fiellin D. Treatment of Heroin Dependence. Annals Of Internal Medicine 2001, 134: 714. DOI: 10.7326/0003-4819-134-8-200104170-00017.
• Perceptions of Benefit and Risk of Patients Undergoing First‐time Elective Percutaneous Coronary RevascularizationHolmboe E, Fiellin D, Cusanelli E, Remetz M, Krumholz H. Perceptions of Benefit and Risk of Patients Undergoing First‐time Elective Percutaneous Coronary Revascularization. Journal Of General Internal Medicine 2000, 15: 632-637. PMID: 11029677, PMCID: PMC1495592, DOI: 10.1046/j.1525-1497.2000.90823.x.
• Screening for Alcohol Problems in Primary Care: A Systematic ReviewFiellin DA, Reid MC, O'Connor PG. Screening for Alcohol Problems in Primary Care: A Systematic Review. JAMA Internal Medicine 2000, 160: 1977-1989. PMID: 10888972, DOI: 10.1001/archinte.160.13.1977.
• Pharmacologic treatment of heroin-dependent patients.O'Connor P, Fiellin D. Pharmacologic treatment of heroin-dependent patients. Annals Of Internal Medicine 2000, 133: 40-54. PMID: 10877739, DOI: 10.7326/0003-4819-133-1-200007040-00008.
• Beyond Diagnosis: Patient Mix and Challenges to Patient Care in Ambulatory Training SitesFiellin D, Concato J. Beyond Diagnosis: Patient Mix and Challenges to Patient Care in Ambulatory Training Sites. The American Journal Of The Medical Sciences 2000, 319: 106. PMID: 10698095, DOI: 10.1097/00000441-200002000-00007.
• New therapies for alcohol problems: application to primary careFiellin D, Reid M, O’Connor P. New therapies for alcohol problems: application to primary care. The American Journal Of Medicine 2000, 108: 227-237. PMID: 10723977, DOI: 10.1016/s0002-9343(99)00448-9.
• Beyond Diagnosis: Patient Mix and Challenges to Patient Care in Ambulatory Training SitesFiellin D, Concato J. Beyond Diagnosis: Patient Mix and Challenges to Patient Care in Ambulatory Training Sites. The American Journal Of The Medical Sciences 2000, 319: 106-110. DOI: 10.1016/s0002-9629(15)40697-4.
• Reducing Bias in Observational Research on Alcohol Withdrawal SyndromeFiellin D, Samet J, O'Connor P. Reducing Bias in Observational Research on Alcohol Withdrawal Syndrome. Substance Abuse 1998, 19: 23-31. PMID: 12511804, DOI: 10.1080/08897079809511370.